✦ LIBER ✦

The influence of gemcitabine and cisplatin schedule on response and survival in advanced non-small cell lung cancer

✍ Scribed by Shepherd, F.A; Abratt, R; Crino, L; Green, M; Sandler, A; Steward, W; Iglesias, J; Anglin, G

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine, ifosfamide and cisplatin in

✍ Wu, M.-F; Tsai, C.-M; Wu, T.-C; Tsao, S.-M; Wu, M.-H; Chern, M.-S; Su, J.-M; Cho 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Treatment of advanced non-small cell lun

✍ Almodovar, M; Dionisio, J; Matias, D; Duro da Costa, J 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Pharmacology of the paclitaxel–cisplatin

✍ J. R. Kroep; E. F. Smit; G. Giaccone; K. Van der Born; J. H. Beijnen; C. J. Van 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 248 KB

Biweekly regimen of cisplatin, gemcitabi

✍ Javier Castro de Carpeño; M. González Barón; J. Aguiar; J. I. Chacón; J. Feliu; 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 230 KB

Gemcitabine and cisplatin in a multimoda

✍ Yang, C H; Tsai, C M; Wang, L S; Lee, Y C; Chang, C J; Lui, L T; Yen, S H; Hsu, 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 97 KB

Phase II study with gemcitabine, ifosfam

✍ Chen, Yuh-Min; Perng, Reury-Perng; Whang-Peng, Jacqueline; Wu, Hsiao-Wei; Lin, W 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 58 KB